MindWalk Holdings (HYFT) Cost of Revenue (2020 - 2026)
MindWalk Holdings (HYFT) reported Cost of Revenue of $1.2 million for Q1 2026, up 79.2% year-over-year from $681180.8 in Q1 2025, and up 115718.96% quarter-over-quarter from $1053.9 in Q4 2025.
MindWalk Holdings (HYFT) Cost of Revenue (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Cost of Revenue data on file, last reported at $1.2 million in Q1 2026.
- Cost of Revenue for Q1 2026 came in at $1.2 million, up 79.2% year-over-year; the trailing twelve-month figure through Jan 2026 was $1.2 million (down 61.15% YoY), and the FY2025 annual result was $8948.5, down 99.9% from the prior year.
- Cost of Revenue rose to $1.2 million in Q1 2026 per HYFT's latest filing, from $1053.9 in the prior quarter.
- Over five years, Cost of Revenue peaked at $2.5 million in Q2 2024 and troughed at $0.96 in Q4 2024.
- A 5-year average of $1.1 million and a median of $1.6 million in 2023 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2024 and 2025: Cost of Revenue slumped 100.0% in 2024, then soared 109764.18% in 2025.
- A 5-year view of Cost of Revenue shows it stood at $1.8 million in 2022, then surged by 30.17% to $2.4 million in 2023, then plunged by 100.0% to $0.96 in 2024, then soared by 109764.18% to $1053.9 in 2025, then soared by 115718.96% to $1.2 million in 2026.
- Business Quant data shows HYFT's Cost of Revenue at $1.2 million in Q1 2026, $1053.9 in Q4 2025, and $1189.2 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 2.05 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 1.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 1.22 Mn |
| Jan 31, 2026 | 1.22 Mn |
| Oct 31, 2025 | 1,053.93 |
| Oct 31, 2025 | 1,053.93 |
| Jul 31, 2025 | 1,189.20 |
| Jul 31, 2025 | 1,189.20 |
| Apr 30, 2025 | 2,354.84 |
| Apr 30, 2025 | 2,354.84 |
| Jan 31, 2025 | 681,180.77 |
| Jan 31, 2025 | 681,180.77 |
| Oct 31, 2024 | 0.96 |
| Oct 31, 2024 | 0.96 |
| Jul 31, 2024 | 1,068.45 |
| Jul 31, 2024 | 1,068.45 |
| Apr 30, 2024 | 2.47 Mn |
| Apr 30, 2024 | 2.47 Mn |
| Jan 31, 2024 | 2.24 Mn |
| Jan 31, 2024 | 2.24 Mn |
| Oct 31, 2023 | 2.36 Mn |
| Oct 31, 2023 | 2.36 Mn |